These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8807070)

  • 1. Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea.
    Hook EW; Pinson GB; Blalock CJ; Johnson RB
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1720-1. PubMed ID: 8807070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of trovafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group.
    Jones RB; Schwebke J; Thorpe EM; Dalu ZA; Leone P; Johnson RB
    Am J Med; 1998 Jan; 104(1):28-32. PubMed ID: 9528716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone treatment failure in gonorrhea. Emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones.
    Deguchi T; Saito I; Tanaka M; Sato K; Deguchi K; Yasuda M; Nakano M; Nishino Y; Kanematsu E; Ozeki S; Kawada Y
    Sex Transm Dis; 1997 May; 24(5):247-50. PubMed ID: 9153731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of a new quinolone (CP-99,219) compared with ciprofloxacin, pefloxacin, azithromycin and penicillin against Neisseria gonorrhoeae.
    van Rijsoort-Vos JH; Stolz E; Verbrugh HA; Kluytmans JA
    J Antimicrob Chemother; 1995 Jul; 36(1):215-8. PubMed ID: 8537268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.
    Akasaka S; Muratani T; Yamada Y; Inatomi H; Takahashi K; Matsumoto T
    J Infect Chemother; 2001 Mar; 7(1):49-50. PubMed ID: 11406757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etest results.
    Jones RN; Barrett MS; Deguchi T
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):193-200. PubMed ID: 9327248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains.
    Thorpe EM; Schwebke JR; Hook EW; Rompalo A; McCormack WM; Mussari KL; Giguere GC; Collins JJ
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2775-80. PubMed ID: 9124839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study.
    Hook EW; Golden MR; Taylor SN; Henry E; Tseng C; Workowski KA; Swerdlow J; Nenninger A; Cammarata S
    Sex Transm Dis; 2019 May; 46(5):279-286. PubMed ID: 30985632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. The STD Study Group.
    Hook EW; McCormack WM; Martin D; Jones RB; Bean K; Maroli AN
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1843-5. PubMed ID: 9257777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological Analysis from a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae.
    Scangarella-Oman NE; Hossain M; Dixon PB; Ingraham K; Min S; Tiffany CA; Perry CR; Raychaudhuri A; Dumont EF; Huang J; Hook EW; Miller LA
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated Chlamydial urethritis and cervicitis. Trovafloxacin Chlamydial Urethritis/Cervicitis Study Group.
    McCormack WM; Dalu ZA; Martin DH; Hook EW; Laisi R; Kell P; Pluck ND; Johnson RB
    Sex Transm Dis; 1999 Oct; 26(9):531-6. PubMed ID: 10534208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of uncomplicated urogenital gonorrhoea in women with a single dose of enoxacin.
    Tegelberg-Stassen MJ; van der Willigen AH; van der Hoek JC; Wagenvoort JH; van Vliet HJ; van Klingeren B; van Joost T; Michel MF; Stolz E
    Eur J Clin Microbiol; 1986 Aug; 5(4):395-8. PubMed ID: 3093221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
    Shultz TR; Tapsall JW; White PA
    Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.
    Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 1999 Jan; 43(1):77-84. PubMed ID: 9869569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.
    Ruiz J; Marco F; Sierra JM; Aguilar L; Garcia-Mendez E; Mensa J; Jiménez De Anta MT; Vila J
    Int J Antimicrob Agents; 2003 Jul; 22(1):73-6. PubMed ID: 12842332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.
    Kirkcaldy RD; Weinstock HS; Moore PC; Philip SS; Wiesenfeld HC; Papp JR; Kerndt PR; Johnson S; Ghanem KG; Hook EW
    Clin Infect Dis; 2014 Oct; 59(8):1083-91. PubMed ID: 25031289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates.
    Tanaka M; Tunoe H; Mochida O; Kanayama A; Saika T; Kobayashi I; Naito S
    Diagn Microbiol Infect Dis; 2000 Oct; 38(2):109-13. PubMed ID: 11035242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.
    Donahue PE; Smith DL; Yellin AE; Mintz SJ; Bur F; Luke DR
    Am J Surg; 1998 Dec; 176(6A Suppl):53S-61S. PubMed ID: 9935258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trovafloxacin.
    Haria M; Lamb HM
    Drugs; 1997 Sep; 54(3):435-45; discussion 446. PubMed ID: 9279505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.